Search Results - "Pérez Ceballos, E."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors by Pérez-Ceballos, E., Rivera, J., Lozano, M. L., Candela, M. J., Corral, J., Guerrero, J. A., Vicente, V.

    Published in Clinical and laboratory haematology (01-08-2004)
    “…Summary With the goal of producing haemostatically effective platelet concentrates (PCs) with a longer shelf‐life, we aimed to identify a simple combination of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells by OSMA, M. M, ORTUNO, F, LOZANO, M. L, GOMEZ-ESPUCH, J, AYALA, F, SANCHEZ-SERRANO, I, PEREZ-CEBALLOS, E, MORALEDA, J. M, VICENTE, V

    Published in Bone marrow transplantation (Basingstoke) (01-06-2001)
    “…Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been widely used after autologous peripheral blood stem cell transplant (APBSCT) in an…”
    Get full text
    Journal Article
  11. 11

    Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation by PEREZ-CEBALLOS, E, VALLEJO, C, CANO, H, AYALA, F, MARTINEZ, F, MORALEDA, J. M, VICENTE, V

    Published in European journal of haematology (01-02-2001)
    “…Although the life-threatening cytomegalovirus (CMV) disease is a well known complication following allogeneic hematopoietic stem cell transplantation (HSCT),…”
    Get full text
    Journal Article
  12. 12

    Prothrombin A19911G and G20210A polymorphisms' role in thrombosis by Pérez‐Ceballos, Elena, Corral, Javier, Alberca, Ignacio, Vayá, Amparo, Llamas, Pilar, Montes, Ramón, González‐Conejero, Rocio, Vicente, Vicente

    Published in British journal of haematology (01-08-2002)
    “…The prothrombin G20210A polymorphism, which correlates with the plasmatic prothombin levels, is the second genetic risk factor for deep venous thrombosis…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Combination Chemotherapy with Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Induces a High Response Rate in Previously Untreated CLL by Bosch, Francesc, Ferrer, A., Villamor, N., Gine, E., Abella, M.A., Gardella, S., Besalduch, J., Gonzalez, M., Altes, A., Escoda, L., Ferrer, S., Gonzalez-Barca, E., Perez-Ceballos, E., Asensi, A., Montserrat, E.

    Published in Blood (16-11-2005)
    “…Treatment with FCM results in responses rates of 60% in relapsed or refractory CLL patients. Against this background, we started a trial of FCM in untreated…”
    Get full text
    Journal Article
  15. 15

    Evaluation of a new whole-blood filter that allows preparation of platelet concentrates by platelet-rich plasma methods by Lozano, Maria L., Pérez-Ceballos, Elena, Rivera, Jose, Paunovic, Dragica, Candela, Maria J., Vicente, Vicente

    Published in Transfusion (Philadelphia, Pa.) (01-12-2003)
    “…BACKGROUND: A novel WBC‐reduction in‐line whole‐blood (WB) filter that does not retain platelets was evaluated to assess the filtration performance and, after…”
    Get full text
    Journal Article
  16. 16

    Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation by PerezCeballos, E., Vallejo, C., Cano, H., Ayala, F., Martínez, F., Moraleda, J. M., Vicente, V.

    Published in European journal of haematology (01-02-2001)
    “…: Although the life‐threatening cytomegalovirus (CMV) disease is a well known complication following allogeneic hematopoietic stem cell transplantation (HSCT),…”
    Get full text
    Journal Article
  17. 17